By IDSE News Staff
The FDA granted emergency use authorization (EUA) to the Xpert Mpox test (Cepheid) for the detection and/or diagnosis of infection with mpox in moderately complex settings, and is considered authorized for use in point of care on GeneXpert Xpress systems (Cepheid), according to a company release.
The test is authorized for use in settings that operate under a Clinical Laboratory Improvement Amendments Certificate of Waiver, Certificate of Registration, Certificate of